HEIDELBERG BIOLABS

Heidelberg Biolabs GmbH is a spin-off company of the German Cancer Research Center (DKFZ) founded in 2019 with the aim to commercialize the advanced methods for extracellular circulating (cell-free) nucleic acids analysis. We currently offer a line of research kits for extracellular RNA isolation, quality control and ultrasensitive detection with RT-qPCR as well as high-throughput sequencing. In addition, we are working on establishing innovative tests for early diagnostics of various disorders based on cell-free RNA and DNA biomarkers. The company is currently located at the Heidelberg Technology Park and the National Center for Tumor Diseases (NCT) - internationally renowned hubs for innovation and liquid biopsies analysis... The research products and services offered by Heidelberg Biolabs and our sales partner Nucleus Biotech are based on thoroughly optimized protocols and various know-how developed at the German Cancer Research Center and University Hospital Heidelberg over the..

Also known as: Heidelberg Biolabs GmbH, The Heidelberg Biolabs GmbH

Primary location: Heidelberg Germany